Mark Mackanos's Colleagues at C. Light Technologies, Inc.
Mark Mackanos's Contact Details
510-679-5160
C. Light Technologies, Inc.
Mark Mackanos's Company Details
C. Light has created a novel and patented retinal eye-tracking technology, using machine learning models, to see eye motion changes that existing technologies can not detect. Pairing this tracking approach with our advanced AI creates an entirely new stream of healthcare data providing a unique digital fingerprint of neurological health.The burden of central nervous system conditions costs the US healthcare system upwards of $800B annually, $24.2B for multiple sclerosis (MS). Specifically, delayed MS diagnoses and unpredictable disease progression create poor patient outcomes and inefficiencies across the healthcare system.Through our novel eye motion data, C. Light provides value throughout the care chain in CNS disorders: better outcomes and peace-of-mind for patients, treatment feedback and revenue for physicians, reduced overall healthcare costs for payers, and fast, objective outcomes measurements for therapeutic developers. Future applications of the core technology can extend to Alzheimer's, Parkinson's, ALS, and concussions.